Cetirizine Hydrochloride

盐酸西替利嗪

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameCetirizine Hydrochloride
Drug Alias Name盐酸西替立嗪Cetrizet HydrochlorideCetirizinum HydrochlorideCetirizina HydrochlorideZyrtec +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsSneezingAbdominal PainJaundice +[21] 
Global Approved IndicationsChronic UrticariaUrticariaRhinitis, Allergic, Seasonal +[5] 
Approved Indications in ChinaRhinitis
Original Approved Country/TerritoryBelgium
Original Approved Date1986/11/06
Country/TerritoryBelgiumCanadaUnited States +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesMubadala Investment CompanyCBC Co LtdHarrow Inc +[15] 
Inactive CompaniesJohnson & Johnson Consumer IncAciex Therapeutics IncGlaxosmithkline Plc +[12] 
Active IndicationsSneezingHypersensitivityChronic Urticaria +[9] 
Inactive IndicationsAbdominal PainJaundicePruritus +[12] 

Other Information

ATC CodeR06AE07
Related LinksWikipediaDrugBankKEGG